Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes
Clinical trial NCT01357252 · COMPLETED
Trial details
- NCT number
- NCT01357252
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-01-01
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.